Ad
related to: moderna
Search results
FDA approves Moderna’s mRNA RSV vaccine
The Hill via AOL· 6 days agoThe Food and Drug Administration (FDA) has approved Moderna’s RSV mRNA vaccine for adults older than 60 years. The approval makes RSV the second disease...
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 1 day agoThe Food and Drug Administration (FDA) has approved mRESVIA, a new vaccine made by Moderna, to help...
Novavax's stock surges almost 300% in the past month
Yahoo Finance· 2 hours agoIf approved, Novavax would finally be able to market its only commercially available product during the fall vaccine season, alongside rivals Pfizer...
FDA approves Moderna's RSV vaccine, its second marketed product
USA Today· 6 days agoThe U.S. Food and Drug Administration has approved Moderna's respiratory syncytial virus vaccine,...
Moderna, Merck shares rise as combined melanoma therapy shows improved survival rate By...
Investing.com· 3 days agoModerna (NASDAQ:MRNA) and Merck (MRK) have released new, more encouraging three-year data on their...
US approves Moderna's RSV vaccine for older adults
AFP via Yahoo News· 6 days agoThe US Food and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults -- marking the first time any...
FDA approves Moderna’s RSV vaccine mRESVIA
Pharmaceutical Technology via Yahoo Finance· 4 days agoModerna has secured approval from the US Food and Drug Administration (FDA) for its mRNA-based respiratory syncytial virus (RSV) vaccine mRESVIA...
Moderna's RSV vaccine for older adults approved
Axios· 6 days agoModerna's RSV shot for adults 60 and older was approved by the Food and Drug Administration on Friday, joining a growing group of vaccines protecting...
FDA approves Moderna’s mRNA RSV vaccine for older adults | CNN
CNN.com· 6 days agoThe US Food and Drug Administration has approved another vaccine to help protect older people from...
RBC Capital lifts Moderna shares target, highlights RSV vaccine approval By Investing.com
Investing.com· 3 days agoOn Monday, RBC (TSX:RY) Capital Markets adjusted its outlook on Moderna (NASDAQ:MRNA) shares,...